Colonial Trust Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Colonial Trust Advisors's ELV Position: Q2 2026 in Review
Colonial Trust Advisors increased its Elevance Health (ELV) stake by 18% in Q2 2026, buying an estimated $13.4K and bringing the position to 236 shares worth $91.3K. The position accounts for 0.01% of the portfolio, ranked #292.
Colonial Trust Advisors first reported a position in ELV in Q3 2022 and has held it in 16 quarters since. The position peaked at $222K in Q4 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Colonial Trust Advisors held 236 shares of Elevance Health worth $91.3K as of Q2 2026.
- Colonial Trust Advisors bought 36 Elevance Health shares in Q2 2026, an estimated $13.4K.
- Elevance Health made up 0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #292 holding.
- Colonial Trust Advisors first reported a position in Elevance Health in Q3 2022 and has held it in 16 quarters since.
- Colonial Trust Advisors's Elevance Health position peaked at $222K in Q4 2022.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.